News

Stay up to date with everything Adastra and the cannabis industry

Adastra Announces Private Placement Financing

June 18, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing company announced today that it will be conducting a non-brokered private placement of units (the “Units“) at a price of $0.30 per Unit for gross proceeds of up to $1,000,000 (the “Offering“),

Read More »

Adastra Provides Update On Annual and Interim Financial Statements

May 29, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”), a  Health Canada Licensed cannabis processing and analytical testing services Company, announces, further to Adastra’s April 24, 2020 news release in relation to the timing of the filing of its year-end financial statements, the corporation now expects to file such documents on or prior to June

Read More »

Adastra Announces Initial Distillate Purchase Order from CannMart

May 22nd, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a  Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of its initial purchase order for bulk distillate from CannMart  Inc. (“CannMart”) a majority owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSX-V: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF). “We are pleased

Read More »

Adastra Labs Announces Reliance Upon Annual Financial Statement Filing Exemption

LANGLEY, BC / ACCESSWIRE / April 24, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) (“Adastra” or the “Company”) as a result of the COVID-19 pandemic, will be relying on the coordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (CSA) on March

Read More »

Adastra Announces Completion of Commissioning and Commencement of Operations

LANGLEY, BC / ACCESSWIRE / April 23, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) (“Adastra”) a provider of same-site Health Canada Licensed cannabis processing and analytical testing services, is pleased to announce the completion of Commissioning and Commencement of Operations “We are pleased to announce the completion of an extensive and rigorous commissioning program that has proven

Read More »

Contact Us

Have a question? Want more information? Looking for a partner to deliver the exceptional service you need for your future business? If you're passionate about cannabis, we'd love to hear from you.

F: 844-874-9893
E: info@adastralabs.ca

5451 275th Street,
Langley, BC, Canada, V4W 3X8

Scroll to Top